The mechanism of efficacy of intravenous immunoglobulin in Kawasaki disease.
Kaneka
K
K
Savage
C O
CO
Pottinger
B E
BE
Shah
V
V
Pearson
J D
JD
Dillon
M J
MJ
D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000187:drug effects; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000494:pharmacology* / Q000627:therapeutic use*; D009080:Mucocutaneous Lymph Node Syndrome / Q000628:therapy*
D016756:Immunoglobulins, Intravenous